On March 28, 2019, theFederal Trade Commission (“FTC”) issued an Opinion and Final Orderagainst Impax Laboratories LLC (“Impax”), ruling that an agreement between Impax and Endo Pharmaceuticals Inc. (“Endo”) to delay market entry of Impax’s generic version of...